Tango Therapeutics TNGX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's operating margin?
- Tango Therapeutics (TNGX) reported operating margin of -206.2% in Q1 2026.
- How has Tango Therapeutics's operating margin changed year-over-year?
- Tango Therapeutics's operating margin increased by 42.1% year-over-year, from -355.9% to -206.2%.
- What is the long-term trend for Tango Therapeutics's operating margin?
- Over 4 years (2021 to 2025), Tango Therapeutics's operating margin has grown at a 3.2% compound annual growth rate (CAGR), from -157.1% to -178.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.